Annals of Oncology Advance Access published online on January 17, 2006
Annals of Oncology, doi:10.1093/annonc/mdj139
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Eindhoven Cancer Registry, Comprehensive Cancer Centre South, Eindhoven, the Netherlands
* To whom correspondence should be addressed.
Background: The aim was to compare long-term survival rates for different types of cancer estimated by means of up to date period analysis with those from more traditional cohort analysis.
Patients and methods: Data from the Eindhoven Cancer Registry were used. In total 140 137 newly diagnosed patients diagnosed between 1980 and 2002 and followed until 1 January 2005 were included. Five-, 10- and 20-year relative survival rates were calculated.
Results: For total cancer in men and women, childhood cancer, rectal cancer, melanoma in women, breast cancer, prostate cancer and all leukaemias, much higher 10-year survival rates were found with period analyses (differences with cohort analyses were 5.1%, 3.6%, 7.4%, 5.6%, 6.5%, 4.0%, 5.1% and 10.5%, respectively). For laryngeal and bladder cancer the 10-year survival rates estimated with period analyses were about 7.5% lower compared with those estimated by means of cohort analyses.
Conclusions: Period analysis, based on the most recent period of diagnosis, enabled us to show higher survival rates for total cancer, childhood cancer, rectal cancer, melanoma, breast cancer, prostate cancer and acute leukaemia, but also lower rates for laryngeal and bladder cancer. Period analysis should be the preferred tool for showing up-to-date survival rates to cancer patients and their physicians.
Received September 13, 2005
Accepted December 14, 2005
original article
Higher long-term cancer survival rates in southeastern Netherlands using up-to-date period analysis
S. Houterman 1 *,
M. L. G. Janssen-Heijnen 1,
L. V. van de Poll-Franse 1,
H. Brenner 2,
and
J. W. W. Coebergh 3
2 German Centre for Research on Ageing, Heidelberg, Germany
3 Eindhoven Cancer Registry, Comprehensive Cancer Centre South, Eindhoven, the Netherlands; Department of Public Health, Erasmus University Medical Centre Rotterdam, the Netherlands
S. Houterman, E-mail: research{at}ikz.nl
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Brenner and T. Hakulinen Maximizing the Benefits of Model-Based Period Analysis of Cancer Patient Survival Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1675 - 1681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Janssen-Heijnen, S Houterman, V. Lemmens, H Brenner, E. Steyerberg, and J. Coebergh Prognosis for long-term survivors of cancer Ann. Onc., August 1, 2007; 18(8): 1408 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Gondos, B Holleczek, V Arndt, C Stegmaier, H Ziegler, and H Brenner Trends in population-based cancer survival in Germany: to what extent does progress reach older patients? Ann. Onc., July 1, 2007; 18(7): 1253 - 1259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E de Vries, S Houterman, M. Janssen-Heijnen, T Nijsten, S. van de Schans, A. Eggermont, and J. Coebergh Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands Ann. Onc., June 1, 2007; 18(6): 1110 - 1116. [Abstract] [Full Text] [PDF]
|
|